ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy

Guan, Guoying; Xie, Jinjiao; Dai, Yamei; Han, Hui*哈尔滨医科大学; 1
Journal of Biological Chemistry2022-3DOI: 10.1016/j.jbc.2022.101725
9被引19阅读
引用收藏
分享

摘要

Endothelial-mesenchymal transition (EndMT) is an important source of myofibroblasts, but also contributes to the progression of diabetic nephropathy (DN). By several differential gene expression analyses from the Gene Expression Omnibus (GEO) database, the tissue factor pathway inhibitor 2 (TFPI2) gene, known as a tumor suppressor, was shown to be dysregulated in DN; however, the potential role and regulatory mechanism of TFPI2 in DN are unclear. Here, we found abnormal upregulation of TFPI2 in the renal cortex of diabetic mice, accompanied by impaired renal function. We also injected a single dose of adeno-associated virus (AAV)2 carrying shRNA targeting TFPI2 intravenously into these mice and found that knockdown of TFPI2 improved renal function and reduced renal fibrosis and cell apoptosis in experimental DN. Furthermore, hyperglycemia-induced EndMT was inhibited in the absence of TFPI2, as evidenced by increased expression of endothelial markers (VE-cadherin and CD31) and decreased expression of mesenchymal markers (alpha-SMA, des-min, and FSP-1). To further explore the mechanism in vitro, human renal glomerular endothelial cells (hRGECs) were incubated in the presence of high glucose or transforming growth factor beta (TGF-beta)2. TFPI2 deficiency inhibited high glucose-induced cell apoptosis and TGF-beta 2-induced EndMT in hRGECs, while overexpression of TFPI2 had the opposite effects. Importantly, TGF-beta 2 is a crucial driver of EndMT, and we found that TFPI2 promoted TGF-beta 2/Smad signaling activation by interferring the interaction of TGF-beta pathway regulators (SMURF2 with SMAD7). Our results show that TFPI2 regulates EndMT and the TGF-beta 2 signaling pathway and is a potential promoter of DN pathogenesis.

学科与关键词

关键词
TISSUE FACTOR PATHWAYGROWTH-FACTOR-BETASMURF2 UBIQUITIN LIGASEKIDNEY FIBROSISRENAL FIBROSISCROSS-TALKCELLSINHIBITOR-2APOPTOSISEXPRESSION
相关
加载中…
  • Endophilin A2 protects against renal fibrosis by targeting TGF-β/Smad signaling
    Mai, Xiaoyi*; Shang, Jinyan; Chen, Qiuyuan; Gu, Shijie; Hong, Yu; Zhou, Jiaguo; Zhang, Minzhou*FASEB Journal, 2022, 36(11): e22603.
  • MYCT1 attenuates renal fibrosis and tubular injury in diabetic kidney disease
    Li, Xin; Fan, Qiu-Ling; Ma, Tian-Kui; Liu, Cong; Shi, Hang; Sun, Yuan-Yuan; Wang, Yue; Ding, Dong-Xue; Tang, Ao; Qin, Yu; Yang, Qi; Ding, Hong; Li, Hang-Yu*; Fu, Wei-Neng*iScience, 2023, 26(9): 107609.
  • MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease
    Li, Jinxiang; Yue, Shuling; Fang, Jingwen; Zeng, Junling; Chen, Siqi; Tian, Jianwei; Nie, Sheng; Liu, Xiaoting; Ding, Hanying*Molecular Therapy-Nucleic Acids, 2022, 28: 488-499.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Biological Chemistry
发表日期
2022-03
卷期
第 298 卷, 第 3 期
页码
101725
DOI
10.1016/j.jbc.2022.101725
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Youth Project of National Natural Science Foundation of China [81600629]; Surface Project of National Natural Science Foundation of China [81671383]

作者

  • G

    Guan, Guoying (第一作者)

    1 · harbin med univ

  • X

    Xie, Jinjiao

    1 · harbin med univ

查看全部 4 位作者收起作者
  • D

    Dai, Yamei

    1 · harbin med univ

  • H

    Han, Hui (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417